会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 83. 发明授权
    • Implantable lead/electrode delivery measurement and feedback system
    • 可植入铅/电极传输测量和反馈系统
    • US08442620B2
    • 2013-05-14
    • US12243674
    • 2008-10-01
    • Enzo SilipoKyungmoo RyuGene A. BornzinJohn W. PooreKeith VictorineZoltan SomogyiNalin Perera
    • Enzo SilipoKyungmoo RyuGene A. BornzinJohn W. PooreKeith VictorineZoltan SomogyiNalin Perera
    • A61B5/053A61B5/00
    • A61N1/05A61N1/08
    • A lead implantation system with an introducer, a lead configured to engage with the introducer such that the introducer can convey the lead to a desired internal target location, and at least one sensor. The sensor is adapted to generate an indicator of desired engagement of the system with the desired target tissue location prior to engagement of the lead with the target tissue. Also a method of implanting an implantable patient lead including advancing a lead implantation assembly towards a desired target location along an introduction axis and monitoring at least one indicator of lead implantation assembly position along the lead introduction axis. At least one indicator can be generated by the lead implantation assembly. Advancing of the lead introduction assembly can be halted when the monitoring indicates contact with the desired target tissue. The patient lead can then be advanced towards the target tissue and fixed to the target tissue.
    • 一种具有引导器的引线植入系统,引线被构造成与导引器接合,使得导引器可将引线传送到期望的内部目标位置,以及至少一个传感器。 所述传感器适于在所述引线与所述目标组织接合之前产生具有期望的目标组织位置的所述系统期望接合的指示器。 还有一种植入可植入患者导线的方法,包括沿着引入轴线将引线植入组件推向所需目标位置,并且沿导线引入轴监测铅植入组件位置的至少一个指示器。 至少一个指示器可以由引线注入组件产生。 当监测指示与所需目标组织接触时,引导组件的推进可以停止。 然后可以将患者导线朝向目标组织推进并固定到靶组织。
    • 88. 发明授权
    • Optimizing anti-tachycardia pacing for terminating atrial fibrillation
    • 优化抗心动过速起搏用于终止房颤
    • US07783352B1
    • 2010-08-24
    • US11473403
    • 2006-06-23
    • Kyungmoo RyuJong GillGene A. Bornzin
    • Kyungmoo RyuJong GillGene A. Bornzin
    • A61N1/08
    • A61N1/3621A61N1/3624A61N1/395
    • An implantable system terminates atrial fibrillation by applying optimized anti-tachycardia pacing (ATP). In one implementation, the system senses and paces at multiple sites on the left atrium. At each site, the system senses reentrant circuits causing the atrial fibrillation. In one implementation, the system applies ATP tuned to the frequency of the reentrant circuit at the electrode that senses the most regular reentrant circuit. In another implementation, the system applies ATP at multiple electrodes, delivering each pulse at each site when the excitable gap is near the site. In other variations, the ATP is optimized for different patterns of sequential, simultaneous, or syncopated delivery to terminate the atrial fibrillation. The system can also monitor multiple heart chambers for cardiac events that favor terminating atrial fibrillation via ATP. The system then times delivery of the ATP according to these cardiac events.
    • 可植入系统通过应用优化的抗心动过速起搏(ATP)来终止房颤。 在一个实施中,系统在左心房的多个位置感觉和步调。 在每个部位,系统检测引起房颤的折返回路。 在一个实现中,该系统将ATP调谐到感测最常规的可重入电路的电极处的可重入电路的频率。 在另一个实施方案中,该系统在多个电极上施加ATP,当可兴奋的间隙在该位置附近时,在每个位置递送每个脉冲。 在其他变体中,ATP针对不同的顺序,同时或间歇递送模式进行优化,以终止心房颤动。 该系统还可以监测多个心室,用于通过ATP终止心房颤动的心脏事件。 然后系统根据这些心脏事件递送ATP。
    • 90. 发明授权
    • Optimizing anti-tachycardia pacing for terminating atrial fibrillation
    • 优化抗心动过速起搏用于终止房颤
    • US08478405B2
    • 2013-07-02
    • US12841012
    • 2010-07-21
    • Kyungmoo RyuJong GillGene A. Bornzin
    • Kyungmoo RyuJong GillGene A. Bornzin
    • A61N1/08
    • A61N1/3621A61N1/3624A61N1/395
    • An implantable system terminates atrial fibrillation by applying optimized anti-tachycardia pacing (ATP). In one implementation, the system senses and paces at multiple sites on the left atrium. At each site, the system senses reentrant circuits causing the atrial fibrillation. In one implementation, the system applies ATP tuned to the frequency of the reentrant circuit at the electrode that senses the most regular reentrant circuit. In another implementation, the system applies ATP at multiple electrodes, delivering each pulse at each site when the excitable gap is near the site. In other variations, the ATP is optimized for different patterns of sequential, simultaneous, or syncopated delivery to terminate the atrial fibrillation. The system can also monitor multiple heart chambers for cardiac events that favor terminating atrial fibrillation via ATP. The system then times delivery of the ATP according to these cardiac events.
    • 可植入系统通过应用优化的抗心动过速起搏(ATP)来终止房颤。 在一个实施中,系统在左心房的多个位置感觉和步调。 在每个部位,系统检测引起房颤的折返回路。 在一个实现中,该系统将ATP调谐到感测最常规的可重入电路的电极处的可重入电路的频率。 在另一个实施方案中,该系统在多个电极上施加ATP,当可兴奋的间隙在该位置附近时,在每个位置递送每个脉冲。 在其他变体中,ATP针对不同的顺序,同时或间歇递送模式进行优化,以终止心房颤动。 该系统还可以监测多个心室,用于通过ATP终止心房颤动的心脏事件。 然后系统根据这些心脏事件递送ATP。